Catalyst Pharmaceuticals (CPRX) Income from Continuing Operations (2010 - 2026)
Catalyst Pharmaceuticals (CPRX) posted Income from Continuing Operations of $63.73 million for Q1 2026, up 12.3% from $56.74 million a year earlier and up 20.9% from the prior quarter.
Powered by 
Analysis
Catalyst Pharmaceuticals (CPRX) Income from Continuing Operations (2010 - 2026) Analysis & Trends
For the trailing twelve months through Mar 31, 2026, Income from Continuing Operations at Catalyst Pharmaceuticals was $221.32 million, up 12.1% year-over-year; for FY2025, it came in at $214.33 million, up 30.8% from FY2024.
- Annual Income from Continuing Operations shows a five-year compound annual growth rate of 23.4% (FY2020 to FY2025).
- In prior years, Catalyst Pharmaceuticals' Income from Continuing Operations was $163.89 million in FY2024 (+129.5%), $71.41 million in FY2023 (-14.0%), $83.08 million in FY2022 (+110.4%) and $39.48 million in FY2021 (-47.3%).
- The Q1 2026 figure stands as the highest quarterly Income from Continuing Operations in data going back to Q3 2010.
- On a year-over-year basis, Income from Continuing Operations increased in six of the last seven quarters, with growth averaging 38.1%.
- The strongest year-over-year quarter for Income from Continuing Operations in the past five years was Q4 2022, with growth of 173.6%; the weakest was Q3 2021, with a decline of 76.2%.
- According to Business Quant data, Income from Continuing Operations for the three prior quarters was $52.7 million (Q4 2025), $52.78 million (Q3 2025) and $52.11 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 1.04 Bn | 134.92 Mn | 63.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 63.73 Mn |
| Dec 31, 2025 | 52.70 Mn |
| Sep 30, 2025 | 52.78 Mn |
| Jun 30, 2025 | 52.11 Mn |
| Mar 31, 2025 | 56.74 Mn |
| Dec 31, 2024 | 55.94 Mn |
| Sep 30, 2024 | 43.88 Mn |
| Jun 30, 2024 | 40.79 Mn |
| Mar 31, 2024 | 23.28 Mn |
| Dec 31, 2023 | 34.84 Mn |
| Sep 30, 2023 | -30.76 Mn |
| Jun 30, 2023 | 37.76 Mn |
| Mar 31, 2023 | 29.57 Mn |
| Dec 31, 2022 | 25.47 Mn |
| Sep 30, 2022 | 22.75 Mn |
| Jun 30, 2022 | 21.62 Mn |
| Mar 31, 2022 | 13.24 Mn |
| Dec 31, 2021 | 9.31 Mn |
| Sep 30, 2021 | 10.33 Mn |
| Jun 30, 2021 | 12.18 Mn |
API Access
Catalyst Pharmaceuticals Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=CPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "CPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=CPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();